Rains JC, Poceta JS (2010) Sleep and headache. Curr Treat Options Neurol 12(1):1–15. https://doi.org/10.1007/s11940-009-0056-y

Article  PubMed  Google Scholar 

Tiseo C, Vacca A, Felbush A, Filimonova T, Gai A, Glazyrina T, Hubalek IA, Marchenko Y, Overeem LH, Piroso S, Tkachev A, Martelletti P, Sacco S, European Headache Federation School of Advanced S (2020) Migraine and sleep disorders: a systematic review. J Headache Pain 21(1):126. https://doi.org/10.1186/s10194-020-01192-5

Article  PubMed  PubMed Central  Google Scholar 

Suzuki K, Suzuki S, Haruyama Y, Fujita H, Hirata K (2024) Clinical impact of restless legs syndrome in patients with migraine: a 12-year, single-center, longitudinal study. Sleep Biol Rhythms. https://doi.org/10.1007/s41105-024-00547-8

Article  PubMed  PubMed Central  Google Scholar 

de Vries Lentsch S, van der Arend BWH, de Boer I, van Zwet EW, MaassenVanDenBrink A, Terwindt GM (2024) Depression and treatment with anti-calcitonin gene related peptide (CGRP) (ligand or receptor) antibodies for migraine. Eur J Neurol 31(2):e16106. https://doi.org/10.1111/ene.16106

Article  PubMed  Google Scholar 

Iannone LF, De Cesaris F, Ferrari A, Benemei S, Fattori D, Chiarugi A (2022) Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine. Cephalalgia 42(13):1323–1330. https://doi.org/10.1177/03331024221111526

Article  PubMed  Google Scholar 

Viticchi G, Di Stefano V, Altamura C, Falsetti L, Torrente A, Brunelli N, Salvemini S, Alonge P, Bartolini M, Di Felice C, Adragna MS, Moroncini G, Vernieri F, Brighina F, Silvestrini M (2024) Effects of prophylactic drug therapies and anti-calcitonin peptide-related monoclonal antibodies on subjective sleep quality: an Italian multicenter study. Sleep Med 117:87–94. https://doi.org/10.1016/j.sleep.2024.03.026

Article  PubMed  Google Scholar 

Suzuki S, Suzuki K, Shiina T, Kobayashi S, Hirata K (2022) Can calcitonin gene-related peptide monoclonal antibody improve migraine and restless legs syndrome? J Neurol Sci 443:120462. https://doi.org/10.1016/j.jns.2022.120462

Article  CAS  PubMed  Google Scholar 

Gonzalez-Quintanilla V, Perez-Pereda S, Gonzalez-Suarez A, Madera J, Toriello M, Pascual J (2021) Restless legs-like syndrome as an emergent adverse event of CGRP monoclonal antibodies: a report of two cases. Cephalalgia 41(11–12):1272–1275. https://doi.org/10.1177/03331024211017879

Article  PubMed  Google Scholar 

Headache_Classification_Committee_of_the_International_Headache_Society_(IHS) (2018) The International classification of Headache disorders, 3rd edition. Cephalalgia 38(1):1–211. https://doi.org/10.1177/0333102417738202

Stewart WF, Lipton RB, Whyte J, Dowson A, Kolodner K, Liberman JN, Sawyer J (1999) An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology 53(5):988–994

Article  CAS  PubMed  Google Scholar 

Tanaka K, Nishigami T, Mibu A, Manfuku M, Yono S, Shinohara Y, Tanabe A, Ono R (2017) Validation of the Japanese version of the Central Sensitization Inventory in patients with musculoskeletal disorders. PLoS ONE 12(12):e0188719. https://doi.org/10.1371/journal.pone.0188719

Article  CAS  PubMed  PubMed Central  Google Scholar 

Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, Zucconi M, Ferri R, Trenkwalder C, Lee HB, International Restless Legs Syndrome Study G (2014) Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria–history, rationale, description, and significance. Sleep Med 15(8):860–873. https://doi.org/10.1016/j.sleep.2014.03.025

Article  PubMed  Google Scholar 

Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C, International Restless Legs Syndrome Study G (2003) Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 4(2):121–132. https://doi.org/10.1016/s1389-9457(02)00258-7

Article  PubMed  Google Scholar 

Kohnen R, Roth T, Grieger F, Moran K, Ondo W (2013) Determination of the minimal clinically important improvement in IRLS total score in patients with moderate to severe restless legs syndrome treated with Rotigotine Transdermal System: a Post Hoc Analysis from a 6-Month Placebo-controlled European study (P02. 056). AAN Enterprises

Allen RP (2013) Minimal clinically significant change for the International Restless Legs Syndrome Study Group rating scale in clinical trials is a score of 3. Sleep Med 14(11):1229. https://doi.org/10.1016/j.sleep.2013.08.001

Article  PubMed  Google Scholar 

Park CG, Chu MK (2022) Interictal plasma glutamate levels are elevated in individuals with episodic and chronic migraine. Sci Rep 12(1):6921. https://doi.org/10.1038/s41598-022-10883-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thuraiaiyah J, Kokoti L, Al-Karagholi MA, Ashina M (2022) Involvement of adenosine signaling pathway in migraine pathophysiology: a systematic review of clinical studies. Cephalalgia 42(8):781–792. https://doi.org/10.1177/03331024221077665

Article  PubMed  Google Scholar 

Wang J, Gao Y, Liu L, Xu W, Zhang P, Liu Y, Qian X, Yu S (2019) The association between migraine and restless legs syndrome: an updated systematic review and meta-analysis. Sleep Med 57:21–29. https://doi.org/10.1016/j.sleep.2019.01.027

Article  PubMed  Google Scholar 

Edvinsson L, Warfvinge K (2019) Recognizing the role of CGRP and CGRP receptors in migraine and its treatment. Cephalalgia 39(3):366–373. https://doi.org/10.1177/0333102417736900

Article  PubMed  Google Scholar 

Charbit AR, Akerman S, Holland PR, Goadsby PJ (2009) Neurons of the dopaminergic/calcitonin gene-related peptide A11 cell group modulate neuronal firing in the trigeminocervical complex: an electrophysiological and immunohistochemical study. J Neurosci 29(40):12532–12541. https://doi.org/10.1523/JNEUROSCI.2887-09.2009

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barry CM, Kestell G, Gillan M, Haberberger RV, Gibbins IL (2015) Sensory nerve fibers containing calcitonin gene-related peptide in gastrocnemius, latissimus dorsi and erector spinae muscles and thoracolumbar fascia in mice. Neuroscience 291:106–117. https://doi.org/10.1016/j.neuroscience.2015.01.062

Article  CAS  PubMed  Google Scholar 

Russo AF, Hay DL (2023) CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond. Physiol Rev 103(2):1565–1644. https://doi.org/10.1152/physrev.00059.2021

Article  CAS  PubMed  Google Scholar 

Rossi SG, Dickerson IM, Rotundo RL (2003) Localization of the calcitonin gene-related peptide receptor complex at the vertebrate neuromuscular junction and its role in regulating acetylcholinesterase expression. J Biol Chem 278(27):24994–25000. https://doi.org/10.1074/jbc.M211379200

Article  CAS  PubMed  Google Scholar 

Czesnik D, Howells J, Bartl M, Veiz E, Ketzler R, Kemmet O, Walters AS, Trenkwalder C, Burke D, Paulus W (2019) I(h) contributes to increased motoneuron excitability in restless legs syndrome. J Physiol 597(2):599–609. https://doi.org/10.1113/JP275341

Article  CAS  PubMed  Google Scholar 

Johnson KW, Morin SM, Wroblewski VJ, Johnson MP (2019) Peripheral and central nervous system distribution of the CGRP neutralizing antibody [(125)I] galcanezumab in male rats. Cephalalgia 39(10):1241–1248. https://doi.org/10.1177/0333102419844711

Article  PubMed  Google Scholar 

Clemens S, Rye D, Hochman S (2006) Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology 67(1):125–130. https://doi.org/10.1212/01.wnl.0000223316.53428.c9

Article  PubMed  Google Scholar 

Rotenberg JS, Canard K, Difazio M (2006) Successful treatment of recalcitrant restless legs syndrome with botulinum toxin type-A. J Clin Sleep Med 2(3):275–278

Article  PubMed  Google Scholar 

Luvisetto S (2021) Botulinum neurotoxins in Central Nervous System: an overview from animal models to human therapy. Toxins (Basel) 13(11). https://doi.org/10.3390/toxins13110751

Ziegeler C, Mehnert J, Asmussen K, May A (2020) Central effects of erenumab in migraine patients: an event-related functional imaging study. Neurology 95(20):e2794–e2802. https://doi.org/10.1212/WNL.0000000000010740

Article  CAS  PubMed  Google Scholar 

Suzuki K, Suzuki S, Haruyama Y, Okamura M, Shiina T, Fujita H, Kobashi G, Sairenchi T, Uchiyama K, Hirata K (2021) Central sensitization in migraine is related to restless legs syndrome. J Neurol 268(4):1395–1401. https://doi.org/10.1007/s00415-020-10295-7

Article  PubMed  Google Scholar 

Danno D, Imai N, Kitamura S, Ishizaki K, Kikui S, Takeshima T (2024) Efficacy of galcanezumab in migraine central sensitization. Sci Rep 14(1):21824. https://doi.org/10.1038/s41598-024-72282-6